Azeus Systems (BBW.SI): A Hong Kong Trust-Infrastructure Compounder With a StockRank of 99

Last week we asked the question: where do we find the next Public Bank?

Here is one candidate. $BBW.SI, Azeus Systems Holdings. Singapore-listed software co, $271 million market cap. Hong Kong-headquartered. Founded in 1991 by an MIT-trained computer scientist who still owns roughly 82 percent of the company three decades later. 5-year revenue CAGR of 21 percent. ROE of 68.9 percent. 8.2 percent dividend yield at a 99 percent payout ratio. StockRank: 99 out of 100.

Idea credit: hat tip to @dirtcheapstocks, who flagged this name a while back.

What Azeus Actually Sells: Board-Level Trust

Azeus's core product is Convene, a board meeting management platform that replaces the traditional paper binder couriered to directors before every board session. The customers are governments, listed companies, financial institutions, and large nonprofits that cannot afford a security breach during a board discussion of a merger, an earnings release, or a regulatory investigation. Named public customers include Fidelity International, Tesco, Mizuho, LafargeHolcim, Barclays, the Central Bank of Trinidad and Tobago, Kenya Airways, Sheffield NHS Trust, America First Credit Union, and Queen Mary University of London.

The origin story is the kind of pivot that looks obvious only in retrospect. Founder Lee Wan Lik spent the company's first 15 years building Hong Kong government IT projects. Then Apple shipped the iPad in 2010. Every listed company in every market was paying a company secretary to print hundreds of pages of board pack, courier them to directors, and chase paper signatures. Azeus shipped a secure digital alternative, and by the middle of the decade Convene had reference customers across 100+ countries.

The unit economics are clean. Roughly $400 per director per year. 77 percent gross margins. 99 percent annual renewal rate. Once a company secretary has trained 12 directors on the platform, the cost of switching is operational pain no governance team will absorb. The switching cost is the moat in concrete operational form.

The Moat Is the Certification Stack

Board meetings surface the most confidential information in any organisation: unreleased earnings, acquisition targets, executive pay, regulatory investigations. The security architecture required to hold that information legitimately is not a marketing checklist; it is a multi-year operational investment. Azeus holds, in combination:

• AES-256 encryption with on-the-fly document decryption. Files are never stored in plaintext on a director's device.
• ISO 27001 + SOC 2 Type II + GDPR alignment. The standard certifications every enterprise software buyer requires.
• CMMI Level 5. The highest software process maturity rating that exists. Azeus has held this continuously since 2003, making it one of very few firms in the world to do so. For government IT procurement across Asia, CMMI Level 5 is frequently a mandatory bid prerequisite. Competitors who lack it cannot bid.
• A 99 percent annual client renewal rate. Management disclosed it publicly. No competitor has publicly claimed to match it.

We covered the broader category of regulatory-and-trust moats in our explainer on what an economic moat actually is. The closest comparable inside our catalog is Frontken (0128.KL) . Same logic, different industry. A vendor-qualification process measured in years becomes the structural barrier that protects unit economics for decades.

"The deepest moats in enterprise software are not in the features. They are in the certifications that took ten years to earn and would take a competitor ten more to replicate."

The CERKS Contract and the FY2028 Cliff

The biggest single fact in the Azeus financial profile today is the CERKS contract. In May 2022, the Hong Kong SAR Government's Office of the Government Chief Information Officer awarded Azeus a HK$1.02 billion contract to design, develop, and deploy a Central Electronic Recordkeeping System for every Hong Kong bureau and department. Roughly 75 percent of the contract value is license and maintenance, not bespoke development labour, which makes CERKS a large-scale software licensing deal that happens to ship inside a project wrapper.

The deployment is in active progress. CERKS licensing revenue grew from HK$41.3 million in FY2024 to HK$141.5 million in FY2025 (roughly 30 percent of total group revenue) as departments went live.

The honest part: this is where the post becomes a real investment decision, not a cheerleading exercise.

In November 2025, Azeus proactively disclosed that final CERKS user numbers will come in lower than originally projected, reducing total contract value by HK$91.1 to HK$116.3 million. Final user count is confirmed by September 2026. Once full deployment completes (projected around FY2027), annual maintenance fees drop to roughly HK$38 million per year, compared with HK$141.5 million in peak FY2025 licensing revenue. That is a HK$100-million-plus annual revenue headwind landing in FY2028. It is the single most important number in the Azeus base case.

Convene's organic growth softens the blow. Convene subscription revenue grew 22 percent in FY2025 (HK$158 million to HK$192.7 million), and management continued to cite Convene as a growth driver even in H1 FY2026 when CERKS was tapering. At a sustained 20-percent compound, Convene subscriptions reach roughly HK$290-310 million by FY2028. That is meaningful, but not enough on its own to fully replace the CERKS peak. The FY2028 trough is priced into the StockRank framework already, which is part of why a 99/100 composite still trades at undemanding multiples relative to global software peers.

Capital Returns: 99 Percent Payout, Zero Dilution

The capital allocation pattern is unusually clean. Lee Wan Lik owns approximately 81 to 82 percent of Azeus. That means roughly 5 million shares of a 30-million-share total constitute the public float. With insider ownership that concentrated, dilution cannot happen without the founder's explicit consent, which has never been given. The share count has been stable for years.

The dividend cadence:

• FY2023: HK$1.90 per share total dividend.
• FY2024: HK$2.80 per share. Up 47 percent.
• FY2025: HK$5.50 per share. Up 96 percent.

That is a 190 percent increase in per-share dividends across two years, paid at roughly 99 percent of earnings. Net cash on the balance sheet sits at HK$294.6 million as of September 30, 2025. Azeus keeps what it needs to operate and sends the rest home. There are no buybacks. There is no need for them when the founder already holds 82 percent.

Lee Wan Lik personally collected roughly HK$136 million in dividends in FY2025 alone. The structural alignment between the controlling shareholder and minority shareholders is the dividend itself. The two groups eat from the same plate. This is the same dynamic we covered in our writeup on Haw Par (H02.SI), another Singapore-listed family-controlled compounder where the dividend policy IS the governance mechanism.

The Other Two Product Bets: Presgo and Convene Records

Two product investments materially shape the post-CERKS trajectory.

Presgo (rebranded from Convene ESG in September 2025) is the ESG reporting platform. It maps to 30+ global sustainability frameworks including the EU's Corporate Sustainability Reporting Directive. The CSRD progressively mandates auditable sustainability reporting for roughly 50,000 European companies through 2028. That is a regulatory-driven market creation event of unusual size, and Azeus is positioning to capture mid-market share (organisations with 1,000-2,000 employees that cannot manage ESG disclosures manually). Revenue is still negligible. The competitive set (Workiva, Sweep, Normative, Greenly, dozens of funded startups) is real. The opportunity is also real. This is the most interesting non-CERKS bet on the table.

Convene Records is the second. CERKS is built on Convene Records, customised for government-wide use. Successful delivery of a HK$1 billion government records-management implementation creates a reference case that almost no competitor in the category can match. Management has publicly signalled the intention to take Convene Records to additional governments in Asia-Pacific and the Middle East post-deployment. No contracts have been disclosed yet, but a single Singapore or Gulf Cooperation Council government win would materially change the post-CERKS trajectory.

Where Convene Wins and Loses Competitively

The board portal market is dominated by Diligent (700,000+ directors, 25,000+ organisations, 50 percent of the Fortune 1000). Nasdaq Boardvantage is the second large player. Convene does not displace Diligent in North American Fortune 500 accounts; that battle is effectively over. What Convene does instead is win in the segments Diligent has under-prioritised:

• Asia-Pacific governments and regulated institutions, where CMMI Level 5 procurement requirements and regional presence matter.
• Middle Eastern institutional buyers, where Saudi Arabia's Vision 2030 is actively driving governance modernisation. Middle East revenue grew 37 percent in FY2025.
• Mid-market organisations globally where Diligent's opaque enterprise pricing is prohibitive.

The 99 percent renewal rate confirms Convene is not losing customers to competitors. It is competing for new logos rather than displacing existing accounts. That is a realistic strategic position for a 200-million-dollar revenue company going against a private-equity-backed global incumbent.

The MoatMap Scorecard: StockRank 99/100

Here is the Azeus Systems MoatMap StockRank:

• Quality: 88/100. ROIC of 72.8 percent. ROE of 68.9 percent. Genuinely exceptional unit economics, net cash balance sheet, founder-controlled, zero dilution over multiple years.
• Value: 81/100. Top quintile globally. P/E of 12.5x. EV/EBITDA of 0.5x (the net cash position absorbs most of the enterprise value, which is itself a clean signal of how cash-rich this balance sheet is). 8.2 percent dividend yield. The factor framework is calling this structurally cheap, not just reasonable.
• Momentum: 29/100. Weak. The market is actively pricing the CERKS revenue cliff. This is the entire reason a Q88+V81 name still trades at single-digit forward P/E.
• Composite StockRank: 99/100. Top 1 percent of the global universe. Quality and Value pulling in the same direction; Momentum pulling against.

A Quality-88 / Value-81 / Momentum-29 profile is the textbook shape of a quality compounder priced for a near-term earnings cliff. The factor framework cannot see the FY2028 trough as cleanly as the deep dive can; the Momentum factor is doing that work indirectly by pricing the chart. The honest investor reads both: framework + cliff. We covered the underlying logic in our guide to factor investing.

Worth flagging: full-year FY2026 results drop this Friday. That print is the first clean read on whether the CERKS transition is as ugly as the Momentum factor fears, or whether Convene's organic growth plus the tapering CERKS tail is absorbing the cliff more gracefully than the chart suggests.

The Question Worth Sitting With

Here is the puzzle. If a founder owns 82 percent of his own company and chooses to pay out 99 percent of earnings rather than reinvest or buy back stock, what is he telling you about the reinvestment opportunities inside the business?

Two honest readings. The bull read says Lee is the right kind of operator: a founder who already owns 82 percent of the equity is mechanically incentivised to retain cash that he believes will earn high returns inside the business, because every dollar reinvested at high ROIC accretes 82 cents to his personal wealth. The fact that he is sending almost everything home as dividends instead means he genuinely does not see large incremental reinvestment opportunities. That is a clean signal of operating discipline: do not build empire for empire's sake. The 5-year revenue CAGR of 21 percent confirms the business is growing well from a modest reinvestment base.

The bear read says the same fact differently: a 21 percent CAGR business that cannot find reinvestment opportunities is a business whose growth is essentially capped by the natural market expansion of board portal adoption. Once Convene is sold to every governance team that needs one, growth stops. If you believe that ceiling is close, the 99 percent payout is the founder acknowledging that the run is mostly behind us.

Reasonable investors will weigh these differently. The Q88/V81/M29 factor profile is consistent with both readings, depending on which time horizon you apply.

The Risks Worth Naming

Three honest concerns to weigh against the thesis:

CERKS revenue cliff in FY2028. Already covered above. This is the single most important modeling input.

Founder concentration and succession. Lee Wan Lik holds 81-82 percent. He built every major government relationship that underpins the business. CEO Michael Yap (since 2022) is the first step in succession, but Lee remains Executive Chairman. If Lee were incapacitated or stepped back suddenly, the deepest customer relationships and institutional knowledge would face real uncertainty. The catalog has covered the same succession question from different angles in QL Resources and Fast Retailing.

Hong Kong concentration. A disproportionate share of government revenue comes from a single SAR. The CERKS contract is already awarded, but the longer-term government pipeline depends on a stable HK SAR procurement environment.

The Bottom Line

Azeus Systems is the kind of business that almost never surfaces in mainstream financial coverage: a small, profitable, founder-controlled Hong Kong software firm with a deep certification moat, a 99 percent renewal rate, and a near-100 percent dividend payout policy. The StockRank of 99 is real. The CERKS cliff in FY2028 is also real. Reasonable investors will weigh these differently depending on their time horizon and their view of Presgo + Convene Records executing to fill the gap.

For investors searching for the next Public Bank type compounder (founder-discipline, dominant sticky-retail category, structural cost or trust advantage, operating in an under-followed market), Azeus checks four out of four of the DNA markers we identified in our writeup on Public Bank (1295.KL). It also pairs naturally with our writeup on Plover Bay (1523.HK) as the other quiet Hong Kong founder-owned compounder with a deep technical moat in our coverage.

For investors using Azeus as a single-name idea, our guide to reviewing your portfolio for weak spots is the right framework for sizing in a low-liquidity Singapore-listed smid-cap with 82 percent founder ownership.

For the full breakdown including segment economics, Convene unit-margin math, the CERKS contract structure in detail, Presgo and Convene Records post-CERKS roadmap, and the management quality assessment, the Azeus Systems Deep Dive is the place to go. It is the source document this post is distilled from.

Disclosure: this article is for informational purposes only and is not investment advice.